Recommendations of Association of Polish Surgeons and Polish Society of Oncological Surgery Gastrointestinal Fistulae in Patients Treated for Malignancy - Diagnostics and Treatment

• Authors: Andrzej Szawłowski , Marek Pertkiewicz , Michał Drews , Adam Dziki , Ireneusz Krasnodębski , Jan Kulig , Paweł Lampe , Zoran Stojcev , Grzegorz Wallner , Wojciech Zegarski
• Languages of publication: EN

Abstracts

EN

Postoperative gastrointestinal fistulae occur more often in patients undergoing surgical treatment for oncological reasons than non-oncological reasons. Fistula is associated with a number of serious sequelae and complications: fluid and electrolyte abnormalities, acid-base abnormalities, local and systemic infection and progressive cachexia that increase morbidity, treatment duration and mortality. Development of fistula additionally delays or prevents specific treatment in oncology. For a patient, a fistula is associated with both physical and mental suffering resulting from concern over further therapy.Although the introduction of advanced surgical techniques, intensive postoperative care, total parenteral nutrition and modern enteral nutrition, resulted in decreased postoperative mortality, however the number of patients with gastrointestinal fistulae hospitalized in the departments of surgery is not decreasing. This may result from the fact that many patients still present for treatment in the advanced phase of their malignancy (clinical stage III/IV according to International Union Against Cancer - UICC) and consequently in worse general status, which poses a high risk of postoperative complications and requires more extensive procedures in progressively older patients. Thus gastrointestinal fistulae still remain a serious clinical problem. Main components of treatment of fistulae include: adequate draining, fighting of infections, artificial nutrition and drugs that decrease gastrointestinal secretion (e.g. somatostatin) that are intended to create conditions for spontaneous fistula healing. Some cases may require an early or late surgical intervention.

Keywords

EN

carcinoma; digestive tract; fistula

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2008
• Volume: 80
• Issue: 12
• Pages: 694-711

Dates

published

1 - 12 - 2008

online

4 - 5 - 2010

Contributors

author

Andrzej Szawłowski

• Clinic of Upper Gastrointestinal Oncology, M. Skłodowska-Curie Center of Oncology-Institute in Warsaw

author

Marek Pertkiewicz

• Clinic of General Surgery and Clinical Nutrition, Medical University in Warsaw

author

Michał Drews

• Chair and Clinic of Surgery, Poznań University of Medical Sciences

author

Adam Dziki

• Clinic of General and Colorectal Surgery, University Clinical Hospital in Łódź

author

Ireneusz Krasnodębski

• Chair and Clinic of General, Gastroenterological Surgery and Nutrition, Medical University in Warsaw

author

Jan Kulig

• Chair of General Surgery and Clinic of Gastroenterological Surgery, Jagiellonian University in Cracow

author

Paweł Lampe

• Chair and Clinic Gastrointestinal Surgery, Medical University of Silesia in Katowice

author

Zoran Stojcev

• Provincial Specialist Hospital, Słupsk

author

Grzegorz Wallner

• 2 Chair and Clinic of General, Gastroenterological and Gastrointestinal Oncological Surgery, Medical University in Lublin

author

Wojciech Zegarski

• Clinic of Oncological Surgery, Ludwik Rydygier Collegium Medicum UMK in Toruń, Center of Oncology in Bydgoszcz

References

• Falconi M, Pederzoli P: The relevance of gastrointestinal fistulae in clinical practice: a review. Gut 2002; 49: (Suppl IV), 2-10.
• Berry SM, Fischer JE: Classification and pathophysiology of enterocutanecus fistulas. Surg Clin N Am 1996; 76: 1009-18.[Crossref]
• Edmunds LH, Williams GH, Welch EC: External fistulas arising from the gastro-intestinal tract. Ann Surg 1960; 152: 445-71.[Crossref][PubMed]
• Soeters PB, Ebeid AM, Fischer JE: Review of 404 patients with gastrointestinal fistulas. Impact of parenteral nutrition. Ann Surg 1979; 190: 189-202.[Crossref]
• Pertkiewicz M: Leczenie żywieniowe pooperacyjnych przetok przewodu pokarmowego. Rozprawa habilitacyjna, Warszawa 1998.
• Rose D, Yarborough MF, Canizaro PC et al, One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986; 163: 345-50.
• Altomare DF, Serio G, Pannarale OC et al.: Predicition of mortality by logistic regresion analysis in patients with postoperative enterocutaneous fistulae. Br J Surg 1990; 77: 450.
• Dudrick SJ, Wilmore DW, Vars HM et al.: Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery 1968; 64: 134.
• Pertkiewicz M, Szczygieł B: Parenteral nutrition in the complex treatment of patients with upper GI tract postoperative fistulas. East-West Exchange in Surgery. Warsaw, Poland 1990. Ed: Y. Idezuki, T. Kajiwara, K. Okaga. str.41.
• Jenkins SA: Emerging differences in the therapeutic efficacy of somatostatin and octreotide in gastroenterology and surgery, Hong Kong; MediMedia, 1996.
• Pederzoli P, Bassi C, Falconi M et al.: Efficacy of octreotide in the prevention complications of elective pancreatic surgery. Br J Surg 1994; 163: 265-69.
• Hesse U, Ysebaert D, de hemptinne B: Role of somatostatin - 14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 2002; 49 (Suppl IV): 11-20.
• Harcour JBD, Boverie JH, Dondelinger RF: Percutaneous Management of Enterocutaneous Fistulas. AJR 1996; 167: 33-38.
• Fischer JE: The pathophysiology of enterocutaneous fistulas. Wolrd J Surg 1983; 7: 446-50.
• Harju E, Pessi T, Koikkalainen T et al.: The treatment of high enterocutaneous fistula with surgical drainage and total parenteral nutrition. Int Surg 1985; 70: 33-38.
• Levy E, Parc R, Cugnenc PH et al.: Fistules de l'intestin grele avec evisceration. La Presse Medicale 1984; 13: 1491.
• Schein M, Decker GA.: Gastroinestinal fistulas associated with large abdominal wall defects: experience with 43 patients. Br J Surg 1990; 77: 97.
• Borison DI, Bloom AD, Pritchard TJ: Treatment of enterocutaneous and colocutaneous fistulas with early surgery or somatostatin analog. Dis Colon Rectum 1992; 35: 635-39.[Crossref][PubMed]
• Torres AJ, Landa JI, Moreno-Azcoita M et al, Somatostatin in the management of gastrointestinal fistulas. Arch Surg 1992; 127: 97-99.[Crossref]
• Byrne WJ, Burke M, Fonkalsrud EW et al.: Home parenteral nutrition. An alternative approach to the management of complicated gastrointestinal fistulas not responding to conventional medical or surgical therapy. JPEN 1979; 3: 355.[Crossref]
• Conter RL, Roof L, Roslyn JJ: Delayed reconstructive surgery for complex enterocutaneous fistulas. Am Surg 1988; 54: 589.[PubMed]
• Lynch AC, Delaney CP, Senagore AJ et al.: Clinical outcome and fastors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 2004; 240(5): 825-31.
• Levy E, Palmer DL, Frileux P et al.: Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the small bowel: a clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 1983; 198: 596.
• Edmunds LH, Williams GM, Welch CE: External fistulas arising from the gastrointestinal tract. Ann Surg 1960; 152: 445.[Crossref]
• Dudrick SJ, Maharaj AR, McKelvey AA: Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 1999; 23, 570-76. Review.[Crossref]
• Reber HA, Austin JL: Abdominal abscesses and gastrointestinal disease. Philadelphia: Saunders 1989; 392-95.
• Falconi M, Sartori N, Caldiron E et al.: Management of digestive tract fistulas. A review. Digestion 1999; 60 (suppl 3): 51-58.[Crossref]
• Draus JM. Jr, Huss SA, Harty NJ et al.: Enterocutaneous fistula: are treatments improving? Surgery 2006; 140: 570-76.[Crossref]
• Cameron AL: The treatment of duodenal fistula. Surg Gynecol Obstet 1923; 37: 599.
• Deitel M: Nutritional management of external gastrointestinal fistulas. Can J Surg 1976; 19: 505.[PubMed]
• Himal HS, Allard JR, Nadeau JE et al.: The importance of adequate nutrition in closure of intestinal fistulas. Br J Surg 1974; 61: 724.
• Kaminsky VM, Deitel M: Nutritional support in the management of external fistulas of the alimentary tract. Br J Surg 1975; 62: 100.
• Fujita H, Skoji M, Noto H et al.: Management of postoperative gastrointestinal fistula. world J Surg 1981; 5: 743.[Crossref]
• Thomas RJ: The response of patients with fistulas of the gastrointestinal tract to parenteral nutrition. Surg Gynecol Obstet 1981; 153: 77.[PubMed]
• Riboli EB, Bertoglio S, Arnulfo G et al.: Treatment of esophageal anastomotic leakages after cancer resection. The role of total parenteral nutrition. JPEN 1986; 10: 82.[Crossref]
• Wretlind A, Sudżijan AW: Wnutriwiennoje pitanije. Interwerbum. Moskwa-Sztokholm 1984.
• Campos AC, Andrade DF, Campos GM et al.: A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg 1999; 188: 483-90.
• Li J, Ren J, Zhu W et al.: Management of enterocutaneous fistulas. 30-year clinical experience. Chin Med J (Engl) 2003; 116: 171-75.
• Hollington P, Mawdsley J, Lim W et al.: An 11-year experience of enterocutaneous fistula. Br J Surg 2004; 91: 1646-51.
• Haffejee AA: Surgical management of high output enterocutaneous fistulae; a 24-year experience. Curr Opin Clin Nutr Metab Care 2004; 7: 309-16.
• Lloyd D, Gabe SM, Winsor AC: Nutrition and management of enterocutaneous fistula. Br J Surg 2006; 93 (9): 1045-55. Review.
• Levy E, Frileux P, Cugnenc PH et al.: High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989; 76: 676-79.
• Wilmore DW, Daly JM, Dudrick SJ et al.: Gastric secretion after parenteral fluid administration. Arch Surg 1971; 102: 509.[Crossref]
• Driscoll DF, Lowell JA, Nompleggi D et al.: Continuous vs intermittent cimetidine infusion in critically ill hospitalized patients. Role of TPN admixture as drug vehicle. Nutrition 1990; 6: 383.
• Boike GM, Sightler SE, Averette HE: Treatment of small intestinal fistulas with octreotide, a somatostatin analog. J Surg Oncol 1992; 49: 63.[Crossref]
• Constanzo J, di Cano N, Martin J et al.: Treatment of external gastrointestinal fistulas by a combination of totalparenteral nutrition and somatostatin. JPEN 1987; 11: 465.[Crossref]
• Leandros E, Antonakis PT, Albanopoulos K et al.: Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol 2004; 18: 303-06.
• Scott NA, Finnegan S, Irving MH: Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. Acta Gastroenterol Belg 1993; 56: 266-70.[PubMed]
• Alexakis N, Sutton R, Neoptolemos JP: Surgical treatment of pancreatic fistula. Dig Surg 2004; 21: 262-74.[Crossref][PubMed]
• Le Moine O, Matos C, Closset J et al.: Endoscopic management of pancreatic fistula after pancreatic and other abdominal surgery. Best Practice & Research in Clinical Gastroenterology 2004; 18: 957-75.
• Morgan KA, Adams DB: Management of internal and external pancreatic fistulas. Surg Clin North Am 2007; 87: 1503-13.[PubMed][Crossref]
• Voss M, Amjad A, Eubanks WS et al.: Surgical Management of Pancreaticocutaneous Fistula. J Gastrointest Surg 2003; 7: 542-46.[Crossref]
• Voss M, Pappas T: Pancreatic fistula. Curr Treat Options Gastroenterol 2002; 5: 345-53.
• Bassi C, Dervenis C, Butturini G et al.: Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
• Reid-Lombardo KM, Farnell MB, Crippa S et al.: Pancreatic Anastomotic Leak Study Group.: Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. J Gastrointest Surg 2007; 11: 1451-58.
• Sandrasegaran K, Tann M, Jennings SG et al.: Disconnection of the pancreatic duct: an important but overlooked complication of severe acute pancreatitis. Radiographics 2007; 27(5): 1389-1400.[Crossref]
• Howard TJ, Stonerock CE, Sarkar J et al.: Contemporary treatment strategies for external pancreatic fistulas. Surgery 1998; 124: 627-32.[Crossref]
• O'Toole D, Vullierme MP, Ponsot P et al.: Diagnosis and management of pancreatic fistulae resulting in pancreatic ascites or pleural effusions in the era of helical CT and magnetic resonance imaging. Gastroenterol Clin Biol 2007; 31: 686-93.
• Butturini G, Daskalaki D, Molinari E et al.: Pancreatic fistula: definition and current problems. J Hepatobiliary Pancreat Surg 2008; 15: 247-51.[Crossref]
• Zeng Q, Zhang Q, Han S et al.: Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas 2008; 36: 18-25.[Crossref]
• Alghamdi AA, Jawas AM, Hart RS: Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis. Can J Surg 2007; 50: 459-66.[PubMed]
• Olejnik P, Ciecierski R, Zgoda M i wsp.: Przetoki trzustkowe. Wiad Lek 1997; 50 Suppl 1 Pt 2: 123-26.
• Pederzoli P, Bassi C, Falconi M et al.: Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet 1968; 163(5): 428-32.
• Brunaud L, Sebbag H, Marchal F et al.: Evaluation de l'efficacite de la somatostatine ou de l'octreotide dans le traitement des fistules pancreatiques externes. Ann Chir 2001; 126: 34-41.[Crossref]
• Segal I, Parekh D, Lipschitz J et al.: Treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (Sandostatin). Digestion 1993; 54 Suppl 1: 53-58.
• Barnes SM, Kontny BG, Prinz RA: Somatostatin analog treatment of pancreatic fistulas. Int J Pancreatol 1993; 14: 181-88.[PubMed]
• Saari A, Schröder T, Kivilaakso E et al.: Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition. Scand J Gastroenterol 1989; 24: 859-62.[Crossref]
• Fischer A, Benz S, Baier P et al.: Endoscopic management of pancreatic fistulas secondary to intraabdominal operation. Surg Endosc 2004; 18: 706-08.[Crossref]
• Safadi BY, Marks JM: Pancreatic-pleural fistula: the role of ERCP in diagnosis and treatment. Gastrointest Endosc 2000; 51: 213-15.[PubMed][Crossref]
• Dhebri AR, Ferran N: Nonsurgical management of pancreaticopleural fistula. JOP 2005; 6: 152-61.[PubMed]
• Lawrence C, Howell DA, Stefan AM et al.: Disconnected pancreatic tail syndrome: potential for endoscopic therapy and results of long-term follow-up. Gastrointest Endosc 2008; 67: 673-79.[Crossref]
• Dobosz M, Dymecki D, Babicki A i wsp.: Postępowanie z pooperacyjnymi przetokami trzustkowymi opornymi na leczenie oktreotydem. Wiad Lek 2001; 54: 380-85.
• Nair RR, Lowy AM, McIntyre B et al.: Fistulojejunostomy for the management of refractory pancreatic fistula. Surgery 2007; 142: 636-42.[Crossref]
• Veillette G, Dominguez I, Ferrone C et al.: Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg 2008; 143: 476-81.[Crossref]

Identifiers

DOI

10.2478/v10035-008-0099-x